SB Drug Discovery - a Sygnature Discovery business aims to revolutionize drug discovery. As a part of Sygnature Discovery, it offers specialized contract research, encompassing cell line generation, assay development, and compound screening services. With a global reputation for outstanding customer service, the company has garnered trust for delivering critical data for novel drug development. Founded in 1994, it operates in the biotechnology and healthcare industries.
Using cutting-edge technologies, SB Drug Discovery prides itself on providing fast, reliable, and customized data to meet client requirements. The expert teams are dedicated to advancing the discovery of future therapeutics. However, specific details such as the headquarters and the latest investment and investors remain undisclosed.
There is no investment information
No recent news or press coverage available for SB Drug Discovery - a Sygnature Discovery business.